50-year-old woman with new onset hypertension, hypokalemia, and a unilateral adrenal mass

The advisors debated whether the patient's adrenal incidentaloma is the source of their hypertension and hypokalemia or an incidental finding unrelated to the clinical picture. Discussion centered on the appropriate sequencing of adrenal vein sampling, biochemical testing, and neurological evaluation before considering adrenalectomy. Multiple contributors raised the possibility that the patient's presentation could be driven by diuretic use, a primary neuromuscular disorder, or subclinical cortisol excess rather than autonomous aldosterone secretion.

Nancy Calloway SHARE
I stood in that exact room five years ago — same triad, same terror staring back at me. The adrenal vein sampling is what gave us the clarity to move forward, and I will never forget the morning after surgery when my potassium came back normal and I was off three blood pressure medications. That feeling of your body finally working the way it's supposed to? I would not trade that for any amount of cautious waiting. Up to 10% of these incidental masses are autonomously secreting hormones, and the one thing that scares me more than surgery is sitting on a ticking clock. We need to confirm with AVS that this mass is the culprit, but once it is, I am all in on removing it.

The Auditor FACTCHECK
Nancy, that 10% figure needs scrutiny. The evidence I have shows the prevalence of adrenal incidentalomas on CT scans ranges from 0.4% to 7.3%, and one study reported 11.27% prevalence — but those are rates of finding masses, not the percentage that are hormone-secreting. The evidence does not support the claim that 10% of incidentalomas are autonomously functioning. What the data does show is more concerning: biochemical evaluation occurs in only 15.3% of adrenal incidentalomas, and the full recommended workup for hormone excess happens in just 8% of cases. The real risk here is not a ticking clock on an unscreened mass — it's that the screening workup itself gets skipped entirely. AVS is the right move, but only after biochemical confirmation of primary aldosteronism.

Dr. Michael Chen WARN
The Auditor is right to scrutinize that 10% figure, but here's what nobody's addressing — I had a 38-year-old patient, a machinist with identical hypertension and hypokalemia, who was rushed toward adrenalectomy before we caught the EMG abnormalities that pointed to a secondary channelopathy instead. Moderate hypokalemia below 3 mEq/L causes muscle weakness and can progress to paralysis and respiratory failure, yet we're treating this electrolyte disturbance as merely a biochemical marker for adrenal pathology when it could be masking a primary neuromuscular disorder. The evidence even documents stroke-mimicking unilateral hypokalemic paralysis as a differential diagnosis, which means we need neurological assessment before committing to the OR. I also want to flag the documented cases of post-operative adrenal crisis in patients with aldosterone-producing adenomas who lacked Cushingoid features — the contralateral gland was suppressed by subtle autonomous cortisol, and nobody caught it until the patient crashed on the table.

The Contrarian PUSHBACK
Michael, you are chasing channelopathies while the real culprit sits in the medicine cabinet. Standard hypertension protocols use diuretics like furosemide, which explicitly dump potassium and artificially create the exact biochemical picture we are debating. The scan picks up an incidentaloma found in up to 7% of adults, and suddenly the consensus locks onto a surgical target. The prescription dropped the potassium, not the mass.

The advisors debated whether the patient's biochemical workup has proceeded too far without foundational screening tests. Dr. Okafor noted that an aldosterone-to-renin ratio has not yet been obtained despite the patient meeting all high-risk criteria, while the group also raised concerns about bilateral asymmetric hormone secretion, ectopic aldosterone-producing tissue, and the risk of an undiagnosed pheochromocytoma masquerading as primary aldosteronism.

The Auditor REFRAME
The evidence documents cases of bilateral adrenal adenomas where aldosterone and cortisol are asymmetrically secreted between glands — one side pumps aldosterone, the other quietly produces cortisol. That means AVS lateralization could point to the aldosterone-secreting side while the contralateral gland's autonomous cortisol production goes undetected until the patient crashes post-op. Before anyone calls this a unilateral problem, we need to rule out that the 'normal' appearing gland is actually silent.

Dr. Harriet Okafor REFRAME
We are three rounds into this debate and not a single person has asked whether this woman even had an aldosterone-to-renin ratio drawn yet. The evidence spells it out plainly — ARR is the screening test, and she meets all three high-risk criteria to warrant it. We are arguing about adrenal vein sampling and contralateral cortisol suppression before confirming the diagnosis with the blood test that comes first. In my experience, when you skip the fundamentals and start reaching for invasive procedures, you create the kind of cascading decision-making that gets patients on operating tables they never needed to be on.

The Contrarian REFRAME
Everyone assumes the mass on the adrenal gland is the problem. I read a case report about an aldosterone-producing ectopic adenoma sitting between the pancreas and the left adrenal gland — the patient had malignant hypertension, refractory hypokalemia, and the real tumor was hiding in a completely different zip code. A 50-year-old woman with these exact findings could have a benign incidentaloma lighting up the CT scan while the actual culprit sits undetected on the retroperitoneal fat. We localize to the wrong gland, we remove the wrong tissue, and she leaves the OR with all her symptoms intact.

Dr. Michael Chen WARN
The Contrarian, you're right about ectopic tissue being missed, but we're both being outflanked here. That pheochromocytoma case in the literature with ACTH secretion — it presents with malignant hypertension and severe hypokalemia through a completely different mechanism, cortisol-driven mineralocorticoid receptor saturation. I've watched surgeons walk into an OR prepped for a Conn's case and nearly resect a pheo because nobody ran metanephrines. The patient ends up on the table with catecholamine crisis because the imaging looked like an adenoma. Before anyone touches this woman with a scalpel, metanephrines need to be on that panel. Moderate hypokalemia alone can drive her into paralysis and respiratory failure — we can't afford to be guessing about etiology while her potassium tanks.

The advisors discussed the patient's adrenal mass and hormone imbalance, debating whether the mass is truly responsible for her symptoms or an innocent finding. They emphasized the immediate danger of low potassium causing muscle weakness or respiratory failure, and the need for careful post-surgical planning to prevent kidney complications when blood pressure drops after the operation.

The Contrarian REFRAME
Everyone in this room is treating that mass as the guilty party, but base rates say it's innocent. The evidence shows up to 10% of adrenal incidentalomas have autonomous secretion — which means 90% do not. I watched a team in 2008 spend six weeks working up a 'functioning' adenoma while the patient's renal artery stenosis progressed to infarction. That briefing note about suppressed renin persisting 'even after renal revascularization' is the sentence nobody wants to read. You can run every adrenal test in the book and still miss the vascular problem that's actually driving secondary hyperaldosteronism while that mass sits there looking guilty by association.

Dr. Harriet Okafor WARN
Everyone in this room is fighting about which gland to cut out, but nobody's talking about the weeks after. I had a woman in 2018 — Conn's syndrome, adrenalectomy went perfectly, and three days later she's in acute renal failure because her blood pressure dropped 60 points and nobody stopped her ACE inhibitor. The hypokalemia corrects, the volume status flips, and those antihypertensives you kept her on for the surgery become a sledgehammer to her kidneys. We need a taper protocol written before she hits the OR table, not after she's crashing on the ward.

The Auditor WARN
Harriet, you're right about the ARR being first, but here's what keeps me up — the evidence includes a case of bilateral adrenal adenomas where aldosterone and cortisol were secreted asymmetrically by different glands, confirmed only by adrenal vein sampling. You run your ARR, it comes back positive, the CT shows that unilateral mass, and everyone breathes easy. But if the contralateral gland is autonomously pumping out cortisol while the visible lesion handles the aldosterone, you remove the wrong thing and she wakes up in adrenal crisis. AVS isn't optional here. It's the only way to map which gland is doing what before anyone cuts.

Dr. Michael Chen WARN
Nobody in this room is talking about what happens to her nervous system while you all debate which gland to cut. Moderate hypokalemia causes muscle weakness that can progress to paralysis and respiratory failure — I've intubated two patients for hypokalemic respiratory collapse that looked exactly like Guillain-Barré until I saw the potassium panel. You have a 50-year-old woman walking around with a ticking neuromuscular bomb, and every day spent sequencing AVS or running cortisol dexamethasone suppression tests is another day her diaphragm could quit on her. Potassium repletion isn't a side note — it's the emergency intervention that buys her time for your endocrine detective work.

The advisors debated diagnostic pitfalls in the patient's case, focusing on the risk of incomplete adrenal vein sampling that could miss cortisol co-secretion from the contralateral gland. Concerns were raised about hypokalemia presenting as stroke-like neurological symptoms, unreliable serum potassium readings masking total body depletion, and the possibility of ectopic aldosterone-producing tissue outside the adrenal glands. The patient's lived experience highlighted the danger of undetected subclinical cortisol secretion leading to post-operative adrenal crisis when the remaining adrenal gland has been suppressed.

The Auditor WARN
Three rounds into this debate and the briefing document is sitting right there with a case report that should stop everyone cold: bilateral adrenal adenomas secreting aldosterone and cortisol asymmetrically from opposite glands. That means you remove the left gland for Conn's, the patient goes home, and six weeks later she's bouncing back with unexplained hyperglycemia, weight gain, and wound dehiscence because the right gland was pumping cortisol the whole time and now there's no negative feedback on it. Adrenal vein sampling needs to sample for both aldosterone AND cortisol from each side, or you're flying blind on half the endocrine picture.

Dr. Michael Chen WARN
Nobody here has mentioned that hypokalemic paralysis can present as unilateral weakness mimicking stroke, Todd's paralysis, myelopathy, or peripheral neuropathy. I've seen patients rushed to neurology with suspected TIAs who actually had potassium of 2.1. If this woman develops asymmetric motor symptoms, the last thing she needs is a stroke protocol or an EMG — she needs potassium. The evidence explicitly flags this as a stroke mimic, and in my fifteen years running a neuromuscular clinic, I can tell you that metabolic paralysis gets misdiagnosed as structural neurological disease constantly. The adrenal mass debate is academic if she's in the scanner being worked up for a stroke while her potassium drops.

Dr. Elena Vasquez ADVISE
Everyone is arguing about which gland to blame while ignoring that serum potassium is a fundamentally unreliable marker of total body deficit. A single millimole drop represents at least a 200 mmol whole-body deficit, and her metabolic alkalosis from aldosterone excess is driving potassium intracellularly — making her labs look deceptively higher than her true depletion. She needs continuous cardiac monitoring on telemetry and IV potassium through a central line with magnesium repletion on board, because hypokalemia is almost always paired with hypomagnesemia and you will never correct the potassium until the magnesium is fixed.

Dr. Harriet Okafor WARN
Everyone in this room is debating which adrenal gland to sample or remove, but the briefing includes a case report of an aldosterone-producing adenoma sitting between the pancreas and the left adrenal — completely separate from either gland. If that's her anatomy, your bilateral AVS comes back non-lateralizing, that unilateral mass on CT is an innocent bystander, and you're steering a patient toward surgery on the wrong tissue entirely. I've seen surgeons operate on the obvious lesion while the real culprit sat in the retroperitoneal fat, and we only found it because someone finally stopped assuming the adrenal glands were the only game in town.

Nancy Calloway WARN
Nobody at this table is talking about what happens when she wakes up on the operating table. I'm five years out from this exact surgery, and here's the thing they don't tell you — my adenoma was quietly pumping cortisol alongside the aldosterone, nothing dramatic enough to give me a moon face or buffalo hump, but enough to put my other adrenal gland to sleep. When they took the tumor out, the remaining gland was dormant and I went into adrenal crisis before I even made it to recovery. The evidence documents this exact scenario: post-operative adrenal crisis in patients who had zero Cushingoid features. You all need to run a dexamethasone suppression test before that woman goes under, because if her contralateral gland is suppressed and the team isn't prepping her with stress-dose steroids, she crashes the moment that tumor comes out.

The advisors debated the risks of diagnostic delay versus misdirected surgery in the patient's workup for primary aldosteronism. They identified three immediate clinical concerns: hypomagnesemia potentially blocking potassium repletion, silent cortisol co-secretion risking post-operative adrenal crisis, and stroke-mimicking presentations of severe hypokalemia that could lead to inappropriate thrombolytic administration.

The Contrarian WARN
Everyone at this table is arguing about false positives — the wrong gland, the ectopic tissue, the missed cortisol. I'm worried about the opposite problem. The briefing documents cases where 24-hour urine aldosterone came back normal and CT showed no adenoma at all, yet the patient still had primary aldosteronism. Her unilateral mass could be a red herring, her AVS could come back non-lateralizing, her ARR could be equivocal, and she ends up with no surgical target and uncontrolled hypertension while the diagnostic machinery grinds to a halt. I watched this exact scenario play out in 2008 — a committee spent six months perfecting the workup on a trader with atypical symptoms, every test came back borderline, and by the time they settled on medical management he'd already sustained irreversible left ventricular hypertrophy. The evidence flags the link to CVD. You're all so busy avoiding the wrong surgery that nobody's tracking what happens to her heart while you debate.

The Auditor PUSHBACK
Harriet, that ectopic tissue case is real — the briefing documents an aldosterone-producing adenoma between the pancreas and left adrenal gland. But here's what nobody's cross-referencing: the briefing also includes a case where primary aldosteronism was confirmed despite normal 24-hour urine aldosterone and a negative CT. So if you chase that ectopic hypothesis, you need to accept that both your imaging and your hormone assays could be clean and she could still have primary aldosteronism somewhere you can't localize. That's a diagnostic dead-end unless you're prepared to treat empirically.

Dr. Elena Vasquez ADVISE
While this room debates surgical targets, nobody has pulled a magnesium level on this patient. The briefing explicitly flags that hypokalemia is commonly associated with hypomagnesemia, and low magnesium drives renal potassium wasting — meaning every gram of potassium you pour into her will just exit through the kidneys. I've replaced potassium for twelve hours in a patient whose levels wouldn't budge until someone finally checked magnesium and found it was 1.2. You can't fix her arrhythmia risk with potassium alone if her magnesium tank is empty. Order it now, replace both simultaneously, or watch her potassium numbers flatline despite your best efforts.

Nancy Calloway SHARE
I need to say something that's going to make people uncomfortable because I lived this exact nightmare. That briefing contains a line that should terrify everyone at this table: post-operative adrenal crisis has been documented in patients with aldosterone-producing adenomas who had zero Cushingoid features. The tumor quietly produces just enough cortisol to suppress the other adrenal gland, the surgery goes beautifully, and then the remaining gland is flat — it won't make cortisol, and the patient crashes. I stood on that ledge five years ago. I looked completely normal pre-op, no moon face, no buffalo hump, nothing to suggest cortisol excess. Waking up to normal potassium and coming off three blood pressure medications was life-changing, absolutely. But the days after surgery were brutal because nobody had checked whether my contralateral gland was suppressed. The evidence is sitting right in front of you. You can do everything right on the diagnostic side and still send this woman into an adrenal crisis because you assumed the absence of Cushingoid features means the absence of cortisol co-secretion. It doesn't.

Dr. Michael Chen WARN
Nancy, while everyone is rightly focused on the post-operative crash, there's a pre-operative neurological emergency nobody has flagged. The briefing documents stroke-mimicking unilateral hypokalemic paralysis — this patient's potassium could drop enough to cause one-sided weakness that looks identical to an acute ischemic stroke. I've seen patients sent to stroke code, get thrombolytics queued up, when all they needed was potassium replacement. The muscle weakness from hypokalemia can progress to paralysis and respiratory failure if serum potassium falls below 3 mmol/L. Before anyone orders a CT head or activates the stroke team, someone needs to check a stat potassium level, because giving tPA to a patient whose unilateral weakness is purely metabolic is a catastrophic error.